A key opinion leader discusses the most significant unmet needs in the evolving spectrum of cardiovascular risk management.
A discussion on recent data updates from the REDUCE-IT trial, and their practical implications for physicians managing cardiovascular risk.
Cardiologist Deepak Bhatt, MD, discusses factors to consider when assessing the need for cardiovascular risk management or reduction.
A key opinion leader discusses effective CV risk prevention measures, challenges to reducing adverse events, and effective patient education resources.
This article reviews the evolving therapeutic landscape for lowering LDL-C and cardiovascular risk, with an emphasis on the role of omega-3 fatty acids.